Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247458.RApnTtE3Oo104yi-nAD9yo2MKWF44bWJx9RfvwwLOnHrg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247458.RApnTtE3Oo104yi-nAD9yo2MKWF44bWJx9RfvwwLOnHrg130_assertion type Assertion NP1247458.RApnTtE3Oo104yi-nAD9yo2MKWF44bWJx9RfvwwLOnHrg130_head.
- NP1247458.RApnTtE3Oo104yi-nAD9yo2MKWF44bWJx9RfvwwLOnHrg130_assertion description "[PTCL is more aggressive and has a poorer prognosis than diffuse large B-cell lymphoma. nm23-H1 was positive in 44.1% of PTCL-NOS patients. nm23-H1 expression was not correlated with age, performance status (PS), lactate dehydrogenase (LDH) level, or stage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247458.RApnTtE3Oo104yi-nAD9yo2MKWF44bWJx9RfvwwLOnHrg130_provenance.
- NP1247458.RApnTtE3Oo104yi-nAD9yo2MKWF44bWJx9RfvwwLOnHrg130_assertion evidence source_evidence_literature NP1247458.RApnTtE3Oo104yi-nAD9yo2MKWF44bWJx9RfvwwLOnHrg130_provenance.
- NP1247458.RApnTtE3Oo104yi-nAD9yo2MKWF44bWJx9RfvwwLOnHrg130_assertion SIO_000772 25501107 NP1247458.RApnTtE3Oo104yi-nAD9yo2MKWF44bWJx9RfvwwLOnHrg130_provenance.
- NP1247458.RApnTtE3Oo104yi-nAD9yo2MKWF44bWJx9RfvwwLOnHrg130_assertion wasDerivedFrom befree-2016 NP1247458.RApnTtE3Oo104yi-nAD9yo2MKWF44bWJx9RfvwwLOnHrg130_provenance.
- NP1247458.RApnTtE3Oo104yi-nAD9yo2MKWF44bWJx9RfvwwLOnHrg130_assertion wasGeneratedBy ECO_0000203 NP1247458.RApnTtE3Oo104yi-nAD9yo2MKWF44bWJx9RfvwwLOnHrg130_provenance.